Get the Stockscreener App
0.00
100.00%
-0.2001
After Hours:
.18
0.18
+
Unity Biotechnology Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.
See More
Previous Close:
$0.2001
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$13.94M
Revenue:
-
Net Income/Loss:
$-52.53M
P/E Ratio:
0.00
EPS:
-3.66
Net Cash Flow:
$-39.93M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$3.10
Unity Biotechnology Inc Stock (UBX) Company Profile
Name
Unity Biotechnology Inc
Sector
Industry
Phone
(650) 416-1192
Address
285 EAST GRAND AVENUE, SOUTH SAN FRANCISCO, CA
Compare UBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
UBX
Unity Biotechnology Inc
|
0.00 | 13.94M | 0 | -52.53M | -39.93M | -3.66 |
|
VRTX
Vertex Pharmaceuticals Inc
|
403.30 | 104.83B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
600.00 | 63.59B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.35 | 60.43B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
ARGX
Argen X Se Adr
|
800.00 | 48.45B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
343.87 | 37.91B | 4.56B | -176.77M | 225.30M | -1.7177 |
Unity Biotechnology Inc Stock (UBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-27-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| May-16-25 | Downgrade | Mizuho | Outperform → Neutral |
| Aug-22-24 | Initiated | Rodman & Renshaw | Buy |
| Nov-16-23 | Upgrade | Wedbush | Neutral → Outperform |
| Jan-04-22 | Upgrade | ROTH Capital | Neutral → Buy |
| Nov-10-21 | Upgrade | Mizuho | Neutral → Buy |
| Jun-28-21 | Upgrade | Citigroup | Sell → Buy |
| Jun-07-21 | Initiated | H.C. Wainwright | Buy |
| Feb-16-21 | Downgrade | Citigroup | Neutral → Sell |
| Aug-18-20 | Downgrade | Citigroup | Buy → Neutral |
| Aug-18-20 | Downgrade | Mizuho | Buy → Neutral |
| Aug-18-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Aug-17-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-28-20 | Initiated | ROTH Capital | Buy |
| Dec-12-19 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-07-19 | Initiated | Cantor Fitzgerald | Overweight |
| Sep-07-18 | Initiated | Mizuho | Buy |
| May-29-18 | Initiated | Citigroup | Buy |
| May-29-18 | Initiated | Goldman | Neutral |
| May-29-18 | Initiated | Morgan Stanley | Overweight |
View All
Unity Biotechnology Inc Stock (UBX) Latest News
Is Unity Biotechnology Inc. stock a defensive play in 2025Weekly Gains Summary & Risk Adjusted Buy/Sell Alerts - newser.com
How Unity Biotechnology Inc. stock benefits from tech adoption2025 Key Lessons & Smart Money Movement Tracker - newser.com
Backtesting results for Unity Biotechnology Inc. trading strategiesIndex Update & Fast Entry High Yield Stock Tips - newser.com
How to monitor Unity Biotechnology Inc. with trend dashboardsPortfolio Risk Summary & Technical Pattern Based Buy Signals - newser.com
Can Unity Biotechnology Inc. rally from current levelsQuarterly Profit Review & Low Drawdown Momentum Trade Ideas - newser.com
How moving averages guide Unity Biotechnology Inc. tradingPortfolio Update Summary & Daily Stock Trend Watchlist - newser.com
Unity Biotechnology Inc Stock Analysis and ForecastFederal Reserve Announcements & Low Risk Wealth Plans - earlytimes.in
Unity Biotechnology files for dissolution and ends lease agreements By Investing.com - Investing.com Nigeria
Unity Biotechnology files for dissolution and ends lease agreements - Investing.com
Unity Biotechnology Files Dissolution Certificate Amid Cost-Cutting - TipRanks
Published on: 2025-09-20 22:56:38 - خودرو بانک
What indicators show strength in Unity Biotechnology Inc.2025 Market Outlook & Fast Momentum Stock Entry Tips - newser.com
Pharma News: Can Unity Biotechnology Inc sustain its profitability2025 Investor Takeaways & Reliable Price Breakout Signals - خودرو بانک
Unity Biotechnology stockholders approve company liquidation and dissolution plan By Investing.com - Investing.com Canada
Candlestick signals on Unity Biotechnology Inc. stock today2025 Support & Resistance & Stock Market Timing Techniques - newser.com
Unity Biotechnology stockholders approve company liquidation and dissolution plan - Investing.com India
Unity Biotechnology Approves Company Liquidation Plan - TipRanks
Unity Biotechnology Inc Stock (UBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.68%
0.38%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):